Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry


Oh S., Goto S., Accetta G., Angchaisuksiri P., Camm A. J., Cools F., ...More

INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.223, pp.543-547, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 223
  • Publication Date: 2016
  • Doi Number: 10.1016/j.ijcard.2016.08.236
  • Journal Name: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.543-547
  • Keywords: International normalized ratio, Atrial fibrillation, Vitamin K antagonist, FACTOR-V-LEIDEN, JAPANESE PATIENTS, ANTIPLATELET THERAPY, WARFARIN, EVENTS, RISK, HEMORRHAGE, REDUCTION, STATEMENT, STROKE
  • Dokuz Eylül University Affiliated: No

Abstract

Objective: To compare the distribution of international normalized ratios (INRs) in patients receiving vitamin K antagonist (VKA) for newly diagnosed atrial fibrillation in Eastern and Southeastern Asia and in other regions of the world (ORW) represented in the ongoing, global observational study GARFIELD-AF.